Skip to content
Search

Latest Stories

Treatment options for severe pregnancy sickness in new NICE draft guidance

For the first time, the National Institute for Health and Care Excellence (NICE) has recommended acupressure and intravenous fluids to treat extreme cases of nausea and vomiting in pregnancy.

In a draft guidance published on Feb 11, NICE has recommended the use of pharmacological antiemetics or anti-sickness medicines in line with guidance from the Royal College of Obstetricians and Gynaecologists.


This replaces the recommendations from NICE’s guidance on antenatal care, published in 2008, and aims to improve consistency of care across the country.

The recommendations are based on evidence collected prior to the Covid-19 pandemic and the draft guidance is out for public consultation until March 24.

The latest update offers practical advice on the care of healthy women and their babies during pregnancy.

It aims to ensure that women are offered regular check-ups, information and support, and includes recommendations on a range of topics from monitoring foetal growth to sleep positions to avoid during pregnancy.

Although evidence supports the benefits of new draft recommendations, such as involving partners in antenatal appointments, the committee recognises that alternative arrangements may need to be made throughout the Covid-19 pandemic.

The guidance suggests that health care practitioners consider virtual appointments and classes, which may be especially beneficial while government restrictions are in place.

Dr Paul Chrisp, director of the Centre for Guidelines at NICE, said: “While non-pharmacological treatments may help the majority of women experiencing nausea and vomiting during pregnancy, hyperemesis gravidarum can be extremely serious,  and it is essential that effective treatment options are available.

“It is our hope that this guidance will help inform clinicians of the value of treatments like antiemetics and acupressure, and enable them to provide care that keeps women safe and healthy throughout their pregnancy.”

Dr Edward Morris, president at the Royal College of Obstetricians and Gynaecologists, said: “We are aware that the sensitivities of the pandemic mean that not all of the new recommendations in this update can be supported at the present time, but our hope is that alternatives may be considered where appropriate.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less